RxDoctor Payments Data

Jon White, MD

Orthopaedic Surgery of the Spine · Orange, CANPI 1306853122

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $611,652 of the $805,644 with a category attached, or 75.9%. 21 manufacturers reported payments, led by Centinel Spine, LLC at 53.0% of the total. Reporting peaked in 2019 at $272,297 and has fallen 93.9% since, to $16,508 in 2025.

$805,644in general payments, 2019–2025

Across 291 payments — averaging $2768.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Centinel Spine, LLC$427K
  • Innovasis Inc$153K
  • Orthofix Medical, Inc.$135K
  • Silony Medical Corp.$41K
  • Spineart USA Inc$23K
  • Surgalign Spine Technologies, Inc.$12K
  • plus $15K from 15 others
$83,816in research payments, 2019–2025

Across 36 payments — averaging $2328.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$84K

What the payments were for

  • Royalty or licence$611,65276%
  • Consulting fees$164,15020%
  • Travel & lodging$19,8102%
  • Food & beverage$10,0311%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$805,644 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$365,957
Medicare patients
421
Services billed
2,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen85$1,229
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen107$942
Gabapentin126$615
Methocarbamol42$384
Oxycodone Hcl38$306
Celecoxib12$242
Tramadol Hcl55$240
Hydromorphone Hcl18$217
Methylprednisolone50$211
Ibuprofen11$115
Meloxicam18$66
Prednisone11$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →